Cost-effectiveness analysis of HLA-B*5801 testing in preventing allopurinol-induced SJS/TEN in Thai population
about
HLA-B allele and haplotype diversity among Thai patients identified by PCR-SSOP: evidence for high risk of drug-induced hypersensitivityUse of HLA-B*58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: national prospective cohort study.Healthcare utilization and cost of Stevens-Johnson syndrome and toxic epidermal necrolysis management in ThailandHLA-B (*) 58:01 for Allopurinol-Induced Cutaneous Adverse Drug Reactions: Implication for Clinical Interpretation in Thailand.Validation of a Rapid, Robust, Inexpensive Screening Method for Detecting the HLA-B*58:01 Allele in the Prevention of Allopurinol-Induced Severe Cutaneous Adverse Reactions.Impact of HLA-B*58:01 allele and allopurinol-induced cutaneous adverse drug reactions: evidence from 21 pharmacogenetic studies.Genetic markers associated with cutaneous adverse drug reactions to allopurinol: a systematic review.Allopurinol hypersensitivity: investigating the cause and minimizing the risk.Diagnostic utility of HLA-B*5801 screening in severe allopurinol hypersensitivity syndrome: an updated systematic review and meta-analysis.A Systematic Review of Economic Evaluations of Pharmacogenetic Testing for Prevention of Adverse Drug Reactions.The cost-effectiveness of HLA-B*5801 screening to guide initial urate-lowering therapy for gout in the United States.Racial disparities in the risk of Stevens-Johnson Syndrome and toxic epidermal necrolysis as urate-lowering drug adverse events in the United States.Is Universal HLA-B*15:02 Screening a Cost-Effective Option in an Ethnically-Diverse Population? A Case Study of Malaysia.The Cost of Penicillin Allergy Evaluation.HLAs: Key regulators of T-cell-mediated drug hypersensitivity.Cost effectiveness analysis of HLA-B*58:01 genotyping prior to initiation of allopurinol for gout.Comparison between the HLA-B∗58 : 01 Allele and Single-Nucleotide Polymorphisms in Chromosome 6 for Prediction of Allopurinol-Induced Severe Cutaneous Adverse Reactions.How to prevent allopurinol hypersensitivity reactions?A cost-utility analysis of dabigatran, enoxaparin, and usual care for venous thromboprophylaxis after hip or knee replacement surgery in Thailand.Validation of a rapid test for HLA-B*58:01/57:01 allele screening to detect individuals at risk for drug-induced hypersensitivity.Pharmacogenetic Markers of Drug Hypersensitivity in a Thai Population
P2860
Q34999573-34159291-C7A0-44D2-88B2-C24ED4366FC2Q36085404-88C280BA-33F6-4381-85BF-BFA303F00D51Q37093603-80E97055-56B9-4EFB-BE8F-3BB70CDF9254Q37100410-5B89D6CD-A7DA-4D01-976B-714B6B72216EQ37404888-A7E2BEE9-B0E4-4EAF-88EC-1225992B80D2Q37697237-9A829C38-5F06-4A44-BCD2-87D87D63996DQ38474868-46C6C0FD-4323-4A8A-92DA-52DC8280083FQ38594891-C58292F9-D2D7-43C6-9C57-A0F48D196889Q38600529-D32DAE04-EF07-4C51-A374-B26F0E2D7039Q38777644-1A4C4C50-50D1-40E3-B679-010765012F36Q39132630-47CA0BD2-FF30-47C6-87EF-9192488D72E8Q39741682-7918DFB9-7F38-47EE-8539-5DE611BAFA92Q40271934-B7C44C17-C938-4072-B0A5-E240D8D56886Q41993304-580A3970-E7D3-4399-B232-1A1E2611B61CQ47320133-9A8CE7E6-FC06-4866-B19C-5AE7D4FEA621Q47731199-0C3D7AC6-4C67-4513-AF5C-190E652D49A8Q48119431-7BADF54E-EF3F-432B-AED4-056E5753D5F1Q49616100-82B5674C-EE43-4EC9-8B0A-7C3F374BD61AQ51781452-D936A89E-A32D-4DDB-A147-5C86977986C5Q53135190-64FFF7BA-58C2-40E7-B4E2-6110072E13E7Q58799157-0A699B4A-68DF-49BA-B4FF-3DB23924A707
P2860
Cost-effectiveness analysis of HLA-B*5801 testing in preventing allopurinol-induced SJS/TEN in Thai population
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Cost-effectiveness analysis of ...... ced SJS/TEN in Thai population
@ast
Cost-effectiveness analysis of ...... ced SJS/TEN in Thai population
@en
type
label
Cost-effectiveness analysis of ...... ced SJS/TEN in Thai population
@ast
Cost-effectiveness analysis of ...... ced SJS/TEN in Thai population
@en
prefLabel
Cost-effectiveness analysis of ...... ced SJS/TEN in Thai population
@ast
Cost-effectiveness analysis of ...... ced SJS/TEN in Thai population
@en
P2093
P2860
P1433
P1476
Cost-effectiveness analysis of ...... ced SJS/TEN in Thai population
@en
P2093
Nathorn Chaiyakunapruk
Ratree Maenthaisong
Wichittra Tassaneeyakul
P2860
P304
P356
10.1371/JOURNAL.PONE.0094294
P407
P577
2014-04-14T00:00:00Z